1. |
高明, 葛明华, 嵇庆海, 等. 甲状腺微小乳头状癌诊断与治疗中国专家共识(2016版). 中国肿瘤临床, 2016, 43(10): 405-411.
|
2. |
Ito Y, Miyauchi A, Oda H. Low-risk papillary microcarcinoma of the thyroid: A review of active surveillance trials. Eur J Surg Oncol, 2018, 44(3): 307-315.
|
3. |
Ahn HS, Kim HJ, Welch HG. Korea’s thyroid-cancer “epidemic”—screening and overdiagnosis. N Engl J Med, 2014, 371(19): 1765-1767.
|
4. |
Zhang L, Wei WJ, Ji QH, et al. Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1 066 patients. J Clin Endocrinol Metab, 2012, 97(4): 1250-1257.
|
5. |
Liu LS, Liang J, Li JH, et al. The incidence and risk factors for central lymph node metastasis in cN0 papillary thyroid microcarcinoma: a meta-analysis. Eur Arch Otorhinolaryngol, 2017, 274(3): 1327-1338.
|
6. |
姜军, 李世超. 分化型甲状腺癌淋巴结转移特点及颈侧方淋巴结清扫术局部应用解剖. 中国实用外科杂志, 2011, 31(5): 380-383.
|
7. |
余小情, 丛阳, 唐蕾, 等. 术前超声漏诊甲状腺癌颈部淋巴结转移的原因分析. 中国超声医学杂志, 2017, 33(2): 101-103.
|
8. |
Wang X, Tan J, Zheng W, et al. A retrospective study of the clinical features in papillary thyroid microcarcinoma depending on age. Nucl Med Commun, 2018, 39(8): 713-719.
|
9. |
中国医师协会外科医师分会甲状腺外科医师委员会, 中国研究型医院学会甲状腺疾病专业委员会. 分化型甲状腺癌颈侧区淋巴结清扫专家共识(2017版). 中国实用外科杂志, 2017, 37(9): 985-991.
|
10. |
Kouvaraki MA, Shapiro SE, Fornage BD, et al. Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. Surgery, 2003, 134(6): 946-954.
|
11. |
Sugitani I, Fujimoto Y, Yamada K, et al. Prospective outcomes of selective lymph node dissection for papillary thyroid carcinoma based on preoperative ultrasonography. World J Surg, 2008, 32(11): 2494-2502.
|
12. |
Feng JW, Ye J, Wu WX, et al. Management of cN0 papillary thyroid microcarcinoma patients according to risk-scoring model for central lymph node metastasis and predictors of recurrence. J Endocrinol Invest, 2020, 43(12): 1807-1817.
|
13. |
Xue S, Wang P, Liu J, et al. Prophylactic central lymph node dissection in cN0 patients with papillary thyroid carcinoma: A retrospective study in China. Asian J Surg, 2016, 39(3): 131-136.
|
14. |
Mao J, Zhang Q, Zhang H, et al. Risk factors for lymph node metastasis in papillary thyroid carcinoma: a systematic review and meta-analysis. Front Endocrinol (Lausanne), 2020, 11: 265.
|
15. |
Sheng L, Shi J, Han B, et al. Predicting factors for central or lateral lymph node metastasis in conventional papillary thyroid microcarcinoma. Am J Surg, 2020, 220(2): 334-340.
|
16. |
Zheng X, Peng C, Gao M, et al. Risk factors for cervical lymph node metastasis in papillary thyroid microcarcinoma: a study of 1 587 patients. Cancer Biol Med, 2019, 16(1): 121-130.
|
17. |
Shattuck TM, Westra WH, Ladenson PW, et al. Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma. N Engl J Med, 2005, 352(23): 2406-2412.
|
18. |
Lin X, Finkelstein SD, Zhu B, et al. Molecular analysis of multifocal papillary thyroid carcinoma. J Mol Endocrinol, 2008, 41(4): 195-203.
|
19. |
Hu D, Zhou J, He W, et al. Risk factors of lateral lymph node metastasis in cN0 papillary thyroid carcinoma. World J Surg Oncol, 2018, 16(1): 30.
|
20. |
黑虎, 秦建武. cN0期甲状腺微小乳头状癌侧颈淋巴结转移危险因素分析. 中国普通外科杂志, 2019, 28(5): 551-557.
|
21. |
Hu D, Lin H, Zeng X, et al. Risk factors for and prediction model of skip metastasis to lateral lymph nodes in papillary thyroid carcinoma. World J Surg, 2020, 44(5): 1498-1505.
|
22. |
Lu HZ, Qiu T, Ying JM, et al. Association between BRAFV600E mutation and the clinicopathological features of solitary papillary thyroid microcarcinoma. Oncol Lett, 2017, 13(3): 1595-1600.
|